2. Update on primary immunodeficiency diseases

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 2 SUPPL. 2, 2006, Pages

  Bonilla, Francisco A ^a   Geha, Raif S ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

Genetic diseases; Human; Immunodeficiency; Immunology; Infection

Indexed keywords

CHEMOKINE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEINASE; TOLL LIKE RECEPTOR;

AGAMMAGLOBULINEMIA; COMBINED IMMUNODEFICIENCY; COMPLEMENT DEFICIENCY; DIGEORGE SYNDROME; GENE THERAPY; GENETIC DISORDER; GENETIC HETEROGENEITY; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERIMMUNOGLOBULINEMIA E; IMMUNE DEFICIENCY; IMMUNOGLOBULIN A DEFICIENCY; INFECTION; LYMPHOCYTE FUNCTION; LYMPHOCYTOPENIA; PHAGOCYTE DYSFUNCTION; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 31544455256     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.09.051     Document Type: Article

References (51)

1. F.A. Bonilla, and R.S. Geha Primary immunodeficiency diseases J Allergy Clin Immunol 111 suppl 2003 S571 S581
2. F.A. Bonilla, I.L. Bernstein, D.A. Khan, Z.K. Ballas, J. Chinen, and M.M. Frank Practice parameter for the diagnosis and management of primary immunodeficiency Ann Allergy Asthma Immunol 94 suppl 2005 S1 S63
3. A. Sawada, Y. Takihara, J.Y. Kim, Y. Matsuda-Hashii, S. Tokimasa, and H. Fujisaki A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans J Clin Invest 112 2003 1707 1713
4. K. Kubota, J.Y. Kim, A. Sawada, S. Tokimasa, H. Fujisaki, and Y. Matsuda-Hashii LRRC8 involved in B cell development belongs to a novel family of leucine-rich repeat proteins FEBS Lett 564 2004 147 152
5. M.E. Conley, A. Broides, V. Hernandez-Trujillo, V. Howard, H. Kanegane, and T. Miyawaki Genetic analysis of patients with defects in early B-cell development Immunol Rev 203 2005 216 234
6. K. Imai, G. Slupphaug, W.I. Lee, P. Revy, S. Nonoyama, and N. Catalan Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination Nat Immunol 4 2003 1023 1028
7. S. Longerich, and U. Storb The contested role of uracil DNA glycosylase in immunoglobulin gene diversification Trends Genet 21 2005 253 256
8. A. Durandy, P. Revy, K. Imai, and A. Fischer Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects Immunol Rev 203 2005 67 79
9. V. Lougaris, R. Badolato, S. Ferrari, and A. Plebani Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features Immunol Rev 203 2005 48 66
10. U. Salzer, A. Maul-Pavicic, C. Cunningham-Rundles, S. Urschel, B.H. Belohradsky, and J. Litzman ICOS deficiency in patients with common variable immunodeficiency Clin Immunol 113 2004 234 240
11. E. Castigli, S.A. Wilson, L. Garibyan, R. Rachid, F. Bonilla, and L. Schneider TACI is mutant in common variable immunodeficiency and IgA deficiency Nat Genet 37 2005 829 834
12. U. Salzer, H.M. Chapel, A.D. Webster, Q. Pan-Hammarstrom, A. Schmitt-Graeff, and M. Schlesier Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans Nat Genet 37 2005 820 828
13. K. Warnatz, A. Denz, R. Drager, M. Braun, C. Groth, and G. Wolff-Vorbeck Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease Blood 99 2002 1544 1551
14. D.M. Stewart, L. Tian, and D.L. Nelson A case of x-linked agammaglobulinemia diagnosed in adulthood Clin Immunol 99 2001 94 99
15. H. Kanegane, S. Tsukada, T. Iwata, T. Futatani, K. Nomura, and J. Yamamoto Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry Clin Exp Immunol 120 2000 512 517
16. M. Morra, O. Silander, S. Calpe, M. Choi, H. Oettgen, and L. Myers Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome Blood 98 2001 1321 1325
17. E. Edwards, S. Razvi, and C. Cunningham-Rundles IgA deficiency: clinical correlates and responses to pneumococcal vaccine Clin Immunol 111 2004 93 97
18. M. Ehrlich The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease Clin Immunol 109 2003 17 28
19. T.J. De Ravel, E. Deckers, P.L. Alliet, P. Petit, and J.P. Fryns The ICF syndrome: new case and update Genet Couns 12 2001 379 385
20. S. Tanaka, M. Teraguchi, M. Hasui, S. Taniuchi, Y. Ikemoto, and Y. Kobayashi Idiopathic CD4+ T-lymphocytopenia in a boy with Down syndrome. Report of a patient and a review of the literature Eur J Pediatr 163 2004 122 123
21. J.S. Orange Human natural killer cell deficiencies and susceptibility to infection Microbes Infect 4 2002 1545 1558
22. M. Vitale, J. Zimmer, R. Castriconi, D. Hanau, L. Donato, and C. Bottino Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells Blood 99 2002 1723 1729
23. J.S. Orange, S.R. Brodeur, A. Jain, F.A. Bonilla, L.C. Schneider, and R. Kretschmer Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations J Clin Invest 109 2002 1501 1509
24. H.K. Dadi, A.J. Simon, and C.M. Roifman Effect of CD3δ deficiency on maturation of α/β and γ/δ T-cell lineages in severe combined immunodeficiency N Engl J Med 349 2003 1821 1828
25. T. Yabe, S. Kawamura, M. Sato, K. Kashiwase, H. Tanaka, and Y. Ishikawa A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination Blood 100 2002 1496 1498
26. E.A. Lindsay, F. Vitelli, H. Su, M. Morishima, T. Huynh, and T. Pramparo Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice Nature 410 2001 97 101
27. H. Yagi, Y. Furutani, H. Hamada, T. Sasaki, S. Asakawa, and S. Minoshima Role of TBX1 in human del22q11.2 syndrome Lancet 362 2003 1366 1373
28. M.L. Markert, M. Sarzotti, D.A. Ozaki, G.D. Sempowski, M.E. Rhein, and L.P. Hale Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients Blood 102 2003 1121 1130
29. J. Chinen, H.M. Rosenblatt, E.O. Smith, W.T. Shearer, and L.M. Noroski Long-term assessment of T-cell populations in DiGeorge syndrome J Allergy Clin Immunol 111 2003 573 579
30. E.E. Perez, A. Bokszczanin, D. McDonald-McGinn, E.H. Zackai, and K.E. Sullivan Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) Pediatrics 112 2003 e325
31. E.H. Moylett, A.N. Wasan, L.M. Noroski, and W.T. Shearer Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity Clin Immunol 112 2004 106 112
32. M.L. Markert, M.J. Alexieff, J. Li, M. Sarzotti, D.A. Ozaki, and B.H. Devlin Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome Blood 104 2004 2574 2581
33. I. Scheimberg, P.H. Hoeger, J.I. Harper, B. Lake, and M. Malone Omenn's syndrome: differential diagnosis in infants with erythroderma and immunodeficiency Pediatr Dev Pathol 4 2001 237 245
34. M. Ege, Y. Ma, B. Manfras, K. Kalwak, H. Lu, and M.R. Lieber Omenn syndrome due to ARTEMIS mutations Blood 105 2005 4179 4186
35. J.S. Orange, O. Levy, and R.S. Geha Human disease resulting from gene mutations that interfere with appropriate nuclear factor-κB activation Immunol Rev 203 2005 21 37
36. C.L. Ku, K. Yang, J. Bustamante, A. Puel, H. von Bernuth, and O.F. Santos Inherited disorders of human Toll-like receptor signaling: immunological implications Immunol Rev 203 2005 10 20
37. G. Courtois, A. Smahi, J. Reichenbach, R. Doffinger, C. Cancrini, and M. Bonnet A hypermorphic IκBα mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency J Clin Invest 112 2003 1108 1115
38. J.S. Orange, O. Levy, S.R. Brodeur, K. Krzewski, R.M. Roy, and J.E. Niemela Human nuclear factor κB essential modulator mutation can result in immunodeficiency without ectodermal dysplasia J Allergy Clin Immunol 114 2004 650 656
39. T. Niehues, J. Reichenbach, J. Neubert, S. Gudowius, A. Puel, and G. Horneff Nuclear factor κB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia J Allergy Clin Immunol 114 2004 1456 1462
40. C. Picard, A. Puel, M. Bonnet, C.L. Ku, J. Bustamante, and K. Yang Pyogenic bacterial infections in humans with IRAK-4 deficiency Science 299 2003 2076 2079
41. P.A. Hernandez, R.J. Gorlin, J.N. Lukens, S. Taniuchi, J. Bohinjec, and F. Francois Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease Nat Genet 34 2003 70 74
42. G.A. Diaz CXCR4 mutations in WHIM syndrome: a misguided immune system? Immunol Rev 203 2005 235 243
43. Z.B. Wang, Y.Q. Liu, and Y.F. Cui Pathways to caspase activation Cell Biol Int 29 2005 489 496
44. H.J. Chun, L. Zheng, M. Ahmad, J. Wang, C.K. Speirs, and R.M. Siegel Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency Nature 419 2002 395 399
45. C. Zeidler, and K. Welte Kostmann syndrome and severe congenital neutropenia Semin Hematol 39 2002 82 88
46. K. Devriendt, A.S. Kim, G. Mathijs, S.G. Frints, M. Schwartz, and J.J. Van Den Oord Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia Nat Genet 27 2001 313 317
47. E.D. Renner, J.M. Puck, S.M. Holland, M. Schmitt, M. Weiss, and M. Frosch Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity J Pediatr 144 2004 93 99
48. B. Grimbacher, S.M. Holland, and J.M. Puck Hyper-IgE syndromes Immunol Rev 203 2005 244 250
49. H.B. Gaspar, K.L. Parsley, S. Howe, D. King, K.C. Gilmour, and J. Sinclair Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector Lancet 364 2004 2181 2187
50. A. Aiuti, S. Slavin, M. Aker, F. Ficara, S. Deola, and A. Mortellaro Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning Science 296 2002 2410 2413
51. E. Check Gene-therapy trials to restart following cancer risk review Nature 434 2005 127